DetectionNew detection device for forensic and security applications
A new biological sampling and detection device could soon be used by first responders in the forensic and security sectors; the patented technology allows for rapid sampling of up to eight targets simultaneously, testing powder, liquids, or surfaces directly and has applications across the forensic and security areas
A new biological sampling and detection device, created by the U.K. Ministry of Defense (MoD) scientist, could soon be used by first responders in the forensic and security sectors in the United Kingdom and abroad.
The device was created and developed by Dr. Peter White of the Defense Science and Technology Laboratory (DSTL). MoD says that he was looking for a hand-held device that could sample and detect a range of hazardous substances and explosives at the same time, to assist frontline troops and counter-terrorism personnel.
The patented technology allows for rapid sampling of up to eight targets simultaneously, testing powder, liquids, or surfaces directly and has applications across the forensic and security areas.
Peter White says: “Devices that are currently fielded do not integrate sampling with detection and are not easy to use if you are wearing gloves. This invention combines a mature established detection technology (similar to that used in pregnancy test kits) into an integrated hand held device that could be used by a generalist frontline operator wearing protective clothing.”
Ploughshare Innovations Ltd, DSTL’s technology transfer company, has licensed the technology to BBI Detection Ltd which is developing products to supply on a global basis.
BBI Detection currently develops and manufactures bespoke detection devices for the security sector but is hoping this new device, which it has named IMASS, for Integrated Multiplex Assay and Sampling System, will be accessible to a wider customer base. MoD notes that levels of interest have been high in overseas markets, including the United States. BBI has made a number of improvements to the device which has many possible applications, including surface testing for food allergens or illegal drugs, or defense uses in bio-threat and explosives detection.
Richard Lamotte, CEO of BBI Detection says: “It’s been incredibly exciting to be part of the development and commercialization of the IMASS device. Obviously its ergonomic design features make it particularly suitable for biodetection in challenging frontline environments. It also has a multitude of applications in the wider diagnostic arena. Discussions with potential customers, both within the U.K. and further afield, have generated significant interest and anticipation for the launch of the final product.”
Meanwhile, DSTL has recently obtained funding from the Home Office to see how IMASS could be developed for use in counterterrorism, by the emergency services.
